| Literature DB >> 30069177 |
Peter Niehoff1, Silla Hey-Koch1.
Abstract
Breast cancer treatment has undergone major changes in the last 20 years. Specifically, the role of axillary lymph node dissection has changed from radical axillary dissection with excision of a high number of lymph nodes to sentinel lymph node biopsy (SLNB). This paradigm shift is associated with a controversial debate regarding the significance of axillary staging, the need for surgery, and the role of radiotherapy. Looking ahead, lymph node staging and axillary treatment might shift from SLNB and/or axillary dissection to ultrasound-guided needle biopsy and irradiation of regional lymph nodes in order to reduce treatment-related sequelae in early-stage breast cancer.Entities:
Keywords: Adjuvant treatment; Breast cancer; Lymph nodes; Radiotherapy
Year: 2018 PMID: 30069177 PMCID: PMC6062724 DOI: 10.1159/000489892
Source DB: PubMed Journal: Breast Care (Basel) ISSN: 1661-3791 Impact factor: 2.860